Clinical Commissioning Policies
Overview
We are consulting on 4 new documents:
- Bortezomib for the Treatment of Refractory Antibody Mediated Rejection Post Kidney Transplant- Internal Medicine
- Eculizamab for the Treatment of Refractory Antibody Mediated Rejection Post Kidney Transplant- Internal Medicine
- Non Invasively Lengthened Spinal Rods for Scoliosis- Trauma
- Dolutegravir for the Treatment of HIV- 1 in Adults and Adolescents- Cancer and Blood
Consultation will be open until 17 September 2014.
If you have any queries about the consultation, please contact Julie Cunningham at julie.cunningham2@nhs.net
Audiences
- Commissioners
Interests
- Specialised commissioning